Combined Histopathological and Molecular Cytogenetic Stratification of Medulloblastoma Patients

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-03-0721
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Definition of Disease-Risk Stratification Groups in Childhood Medulloblastoma Using Combined Clinical, Pathologic, and Molecular Variables

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2011English

Risk Stratification of Childhood Medulloblastoma in the Molecular Era: The Current Consensus

Acta Neuropathologica
Forensic MedicineMolecular NeurosciencePathologyNeurologyCellular
2016English

Clinical and Molecular Cytogenetic Study of 38 Williams-Beuren Syndrome Tunisian Patients

Open Journal of Genetics
2014English

Precise Determination of Primary Cytogenetic Abnormalities Provides Added Value for Stratification of Chronic Lymphocytic Leukemia Patients

Neoplasma
Cancer Research
2019English

Results of Cytogenetic and Molecular Cytogenetic Studies in Relapce/Refractory of Multiple Myeloma

Innovative Biosystems and Bioengineering
2018English

Histopathological Factors Influencing Results of Combined Treatment in Patients With Laryngeal Cancer

Polish Journal of Pathology
MedicineForensic MedicinePathology
2015English

Ring Chromosome 18: Clinical, Cytogenetic and Molecular Genetic Studies on Four Patients

International Journal of Human Genetics
Genetics
2004English

Potent Antineoplastic Effects of Combined PI3Kα-MNK Inhibition in Medulloblastoma

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2019English

Molecular Cytogenetic Study of the Nf2 Gene Deletion in Meningioma in Sudanese Patients

Balkan Journal of Medical Genetics
Genetics
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy